Medirom Healthcare Technologies (MRM) Common Equity (2019 - 2025)

Medirom Healthcare Technologies' Common Equity history runs 7 years deep, the most recent figure standing at $1.7 million for Q2 2025.

• In Q2 2025, Common Equity changed N/A year-over-year to $1.7 million; the TTM figure through Jun 2025 stood at $1.7 million (changed N/A YoY), while the FY2024 annual figure was $6.1 million, up 320.17% from the prior year.
• Common Equity was $1.7 million for Q2 2025 at Medirom Healthcare Technologies, down from $6.1 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $6.1 million in Q4 2024 to a low of -$1.8 million in Q4 2021.
• Historically, Common Equity has averaged $1.5 million across 5 years, with a median of $1.6 million in 2023.
• The sharpest annual moves came in 2021 and 2023: Common Equity slumped 138.99% in 2021, then soared 447.62% in 2023.
• A 5-year view of Common Equity shows it stood at -$1.8 million in 2021, then soared by 77.07% to -$420296.4 in 2022, then surged by 447.62% to $1.5 million in 2023, then jumped by 320.17% to $6.1 million in 2024, then tumbled by 72.67% to $1.7 million in 2025.
• The last three Common Equity figures came in at $1.7 million (Q2 2025), $6.1 million (Q4 2024), and $1.5 million (Q4 2023), per Business Quant data.